AMBER HALL: Open Payments
NPI 1487381695 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 19 payments from 12 companies in 2025. Trend: 2023 $287 · 2024 $529 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| ARGENX US, INC. | 4 | $87 |
| BIOTRONIK NRO, Inc. | 2 | $51 |
| Lundbeck LLC | 2 | $49 |
| Grifols USA, LLC | 2 | $40 |
| ABBVIE INC. | 2 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| GE HEALTHCARE | 1 | $25 |
| Eisai Inc. | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $18 |
| Saluda Medical Americas, Inc. | 1 | $18 |
Products named: VYVGART HYTRULO, VYEPTI, Gamunex-C, UBRELVY, Xeomin, Prospera, Leqembi, REXULTI.
Industry payments across LA — which companies pay providers there.
